Atlas Trials

Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of BMS-708163

Clinical trial NCT01079819 · COMPLETED

Trial details

NCT number
NCT01079819
Sponsor
Bristol-Myers Squibb
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Alzheimer's Disease
Start date
2010-04-01
Primary completion
2010-12-01
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.